(Fox Business) On Thursday, February 4, Johnson & Johnson submitted its single-dose vaccine to the FDA for emergency use authorization. If approved, this will be a third vaccine option available. As of last week, the vaccine was about 72% effective. Click Here to read more.
PO Box 232, LaGrange, KY 40031